Polydatin Helps Treat Acute Pancreatitis by Targeting NLRP3 Inflammasome
Author Information
Author(s): Yang Jiashu, Jiao Chenyang, Liu Nannan, Liu Wen, Wang Yueyao, Pan Ying, Kong Lingdong, Guo Wenjie, Xu Qiang
Primary Institution: State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China
Hypothesis
Can polydatin effectively inhibit the NLRP3 inflammasome to alleviate acute pancreatitis?
Conclusion
Polydatin disrupts the NLRP3 inflammasome complex and shows potential as a treatment for acute pancreatitis.
Supporting Evidence
- Polydatin was found to inhibit the formation of the NLRP3 inflammasome complex.
- Polydatin treatment led to reduced levels of inflammatory cytokines in animal models.
- HSP90α was identified as a target of polydatin, crucial for NLRP3 stability.
- Polydatin showed effectiveness against both wild-type and mutant forms of NLRP3.
Takeaway
Polydatin is a natural compound that can help reduce inflammation in the body by targeting a specific protein complex involved in diseases.
Methodology
The study used various assays to investigate the effects of polydatin on the NLRP3 inflammasome in cell cultures and animal models.
Limitations
The study primarily focused on in vitro and animal models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website